StartUPDATES: New developments from healthcare startups

22 Jul 2022
medcitynews.com
AntibodyCollaborate
Carrum Health announced a partnership with Cleveland Clinic Weston Hospital in South Florida to expand the availability of complex joint, spine and bariatric care to self-insured companies and their employees in Florida. Building on a successful collaboration to offer Carrum Health members access to high-quality complex cardiac care through Cleveland Clinic’s Heart, Vascular & Thoracic Institute in Ohio, this expansion into Florida, with the addition of three new service lines, will extend the cost-savings benefits to even more members. “Carrum Health is committed to guiding patients to the highest quality, most appropriate care and avoid unnecessary surgeries. We are thrilled to strengthen our collaboration in Florida to offer more regional options for world-renowned care,” said Sach Jain, CEO and founder of Carrum Health. “Our members have been pleased with the cardiac care through our existing relationship with Cleveland Clinic in Ohio and we’re excited to expand our footprint into Florida and offer additional services to make an even bigger impact for our members and add value to employers at a time when cost reduction is so critical.” Carrum introduced a new model of care that moves away from the high-cost fee-for-service model, and brings value-based care to surgeries with a technology-first approach to simplify how care is paid for and delivered. The Carrum benefit includes the industry’s first and only Centers of Excellence platform and a smartphone app that provides complete member support. Members typically never pay any medical costs in the Carrum model – no co-pays, no deductibles, no surprise bills. BigHat Biosciences, which designs safer, more effective antibody therapies for patients using machine learning and synthetic biology, closed a $75 million Series B round in July 2022. Among the company’s investors are: Andreessen Horowitz, Section 32, 8VC, Amgen Ventures, Bristol Myers Squibb, and AME Cloud Ventures, among others. The company has integrated a wet lab for high-speed characterization with machine learning technologies to guide the search for better antibodies. To read more, click here. A male contraception company, YourChoice Therapeutics, has raised $15 million in Series A funds, CEO Akash Bakshi revealed in an interview with Axios. Future Ventures led the round with participation from Refactor, Knollwood, North South Ventures, RH Capital and Olive Tree Capital participated, according to the story. To read more, click here. Cartography Biosciences, a precision medicine company creating therapeutics guided by a comprehensive antigen atlas for immuno-oncology targets, launched this month, raising $57 million in a Series A round. 8VC led the funding round with participation from existing investors Andreessen Horowitz, which led Cartography’s seed financing, and Wing VC, which was also a seed investor. New investors taking part in the round include Catalio Capital Management, ARTIS Ventures, Alexandria Venture Investments, AME Cloud Ventures, the Cancer Research InstituteCancer Research Institute, and Gaingels. To read more, click here. Picture: akindo, Getty Images
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
Targets
-
Drugs
-
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.